OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to fexofenadine HCl (CAS RN 153439-40-8). In addition, this monograph contains the pediatric ADE. Fexofenadine, the active metabolite of terfenadine, is indicated for chronic hives and seasonal allergic runny nose. Fexofenadine, the active metabolite of terfenadine, is a long lasting H1-receptor antagonist (antihistamine). Fexofenadine inhibits the release of histamine from mast cells and selectively antagonizes peripheral H1-receptor activity in the GI tract, large blood vessels, and bronchial smooth muscle, thereby blocking the action of histamine that leads to nasal congestion, runny nose, and other allergic reaction symptoms. It does not enter the brain, unlike most other antihistamines, and therefore, does not cause drowsiness; it also lacks the cardiotoxic potential of its parent drug, terfenadine.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Fexofenadine, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.